ホーム › 結腸癌 › マサチューセッツ州 › Boston
Boston、MAにおける結腸癌の臨床試験
Bostonとその周辺地域（約30マイル以内）の拠点で、結腸癌に関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Distance-Based Exercise to Preserve Function and Prevent Disability
被験者募集中
- Dana-Farber Cancer Institute, Boston
A Study of PHN-012 in Patients With Advanced Solid Tumors
被験者募集中第1相
- PHN-012-001 Site, Boston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第3相
- Brigham and Women's Hospital (BWH), Boston
- Dana-Farber Cancer Institute (DFCI), Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- Dana Farber Cancer Institute, Boston
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
被験者募集中第1/2相
- Massachusetts General Hospital - Main Campus, Boston
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
被験者募集中第3相
- Massachusetts General Hospital, Boston
- Oncura Health, Boston
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
被験者募集中
- Dana Farber Cancer Institute, Boston
Resilience and Equity in Aging, Cancer, and Health (REACH)
被験者募集中
- Dana-Farber Cancer Institute, Boston
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
被験者募集中
- Massachusetts General Hospital Cancer Center, Boston
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
被験者募集中第2/3相
- Tufts Medical Center, Boston
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
被験者募集中観察研究
- Dana-Farber Cancer Institute, Boston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
被験者募集中第1相
- Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
被験者募集中第1相
- Research Site, Boston
- Research Site, Boston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
被験者募集中第1相
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
被験者募集中第1/2相
- Massachusetts General Hospital,, Boston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
被験者募集中第1/2相
- Dana Farber Cancer Institute, Boston
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
被験者募集中早期第1相
- Dana-Farber Cancer Institute, Boston
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
被験者募集中観察研究
- Dana Farber Cancer Institute, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- Massachusetts General Hospital, Boston
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
被験者募集中
- Dana-Farber Cancer Institute, Boston
Building Connections
被験者募集中
- Disparities Research Unit, Massachusetts General Hospital, Boston
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
被験者募集中健康なボランティア歓迎
- Codman Square Health Center, Boston
- East Boston Neighborhood Health Center, East Boston · 2マイル先
他の都市における結腸癌の試験
- New York City, NY22件の研究
- Houston, TX20件の研究
- Los Angeles, CA16件の研究
- Nashville, TN16件の研究
- St. Louis, MO15件の研究
- Arlington, VA15件の研究
- Chicago, IL14件の研究
- San Antonio, TX14件の研究
- Baldwin Park, CA14件の研究
- Baltimore, MD13件の研究
- Tampa, FL13件の研究
- Washington, DC12件の研究
Bostonにおける他の研究
- 乳がん112件の研究
- 非小細胞肺癌90件の研究
- がん（全種類）85件の研究
- 転移性癌63件の研究
- 大腸癌63件の研究
- 肺がん62件の研究
- 卵巣がん61件の研究
- 前立腺がん59件の研究
- うつ病52件の研究
- 子宮内膜がん50件の研究
- 心不全44件の研究
- 急性骨髄性白血病44件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。